Total Payments
$2,302
2024 Payments
$974.49
Companies
17
Transactions
77
Medicare Patients
2,114
Medicare Billing
$126,114
Payment Breakdown by Category
Food & Beverage$2,239 (97.3%)
Education$63.26 (2.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,239 | 75 | 97.3% |
| Education | $63.26 | 2 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $543.12 | 11 | $0 (2024) |
| ABBVIE INC. | $433.91 | 19 | $0 (2024) |
| Lilly USA, LLC | $245.22 | 12 | $0 (2024) |
| Dermavant Sciences, Inc. | $236.87 | 2 | $0 (2024) |
| Galderma Laboratories, L.P. | $140.26 | 3 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $131.94 | 9 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $123.10 | 2 | $0 (2024) |
| Janssen Biotech, Inc. | $89.54 | 3 | $0 (2023) |
| LEO Pharma Inc. | $74.62 | 3 | $0 (2024) |
| UCB, Inc. | $63.15 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $974.49 | 31 | Amgen Inc. ($307.80) |
| 2023 | $836.58 | 24 | Amgen Inc. ($235.32) |
| 2022 | $110.87 | 6 | ABBVIE INC. ($60.97) |
| 2021 | $380.19 | 16 | AbbVie Inc. ($272.16) |
All Payment Transactions
77 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $9.18 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: Dermatology | ||||||
| 11/07/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $121.73 | General |
| Category: Inflammation | ||||||
| 11/07/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $9.25 | General |
| Category: Dermatology | ||||||
| 10/31/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $3.02 | General |
| Category: Dermatology | ||||||
| 10/22/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Inflammation | ||||||
| 10/16/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $7.67 | General |
| Category: Dermatology | ||||||
| 10/05/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $135.38 | General |
| Category: Inflammation | ||||||
| 10/02/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $109.15 | General |
| 10/02/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: DERMATOLOGY | ||||||
| 09/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Immunology | ||||||
| 09/10/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Inflammation | ||||||
| 09/05/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Dermatology | ||||||
| 08/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $15.13 | General |
| 08/07/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: DERMATOLOGY | ||||||
| 07/15/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Dermatology | ||||||
| 06/13/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $24.19 | General |
| Category: Dermatology | ||||||
| 06/11/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: ACNE | ||||||
| 04/23/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Immunology | ||||||
| 03/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $29.59 | General |
| Category: Immunology | ||||||
| 02/13/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Dermatology | ||||||
| 02/13/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 514 | 841 | $83,869 | $36,967 |
| 2022 | 1 | 21 | 21 | $2,415 | $1,247 |
| 2021 | 8 | 555 | 869 | $96,771 | $23,191 |
| 2020 | 9 | 1,024 | 1,735 | $224,437 | $64,709 |
Total Patients
2,114
Total Services
3,466
Medicare Billing
$126,114
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 115 | 194 | $18,818 | $11,144 | 59.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 62 | 68 | $10,296 | $5,179 | 50.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 54 | 73 | $12,045 | $4,899 | 40.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 74 | 79 | $9,085 | $4,268 | 47.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 52 | 79 | $9,480 | $2,899 | 30.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $5,510 | $2,709 | 49.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 45 | 50 | $7,000 | $2,488 | 35.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 31 | 31 | $4,495 | $1,950 | 43.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 37 | 221 | $5,525 | $959.31 | 17.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 15 | 17 | $1,615 | $471.08 | 29.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 21 | 21 | $2,415 | $1,247 | 51.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 174 | 195 | $25,165 | $7,929 | 31.5% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 92 | 108 | $21,924 | $6,584 | 30.0% |
| 17000 | Destruction of skin growth | Office | 2021 | 87 | 100 | $14,935 | $2,248 | 15.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 40 | 44 | $8,422 | $1,978 | 23.5% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 45 | 48 | $8,476 | $1,866 | 22.0% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 62 | 317 | $11,095 | $1,145 | 10.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 35 | 37 | $2,897 | $975.26 | 33.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 20 | 20 | $3,857 | $465.73 | 12.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 297 | 437 | $83,642 | $27,106 | 32.4% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 130 | 161 | $32,683 | $10,896 | 33.3% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 111 | 124 | $21,897 | $6,894 | 31.5% |
| 17000 | Destruction of skin growth | Office | 2020 | 146 | 202 | $30,169 | $6,006 | 19.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 103 | 119 | $15,357 | $5,062 | 33.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 73 | 73 | $14,078 | $4,153 | 29.5% |
About Rebecca Morrow, PA-C
Rebecca Morrow, PA-C is a Physician Assistant healthcare provider based in Henderson, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/19/2010. The National Provider Identifier (NPI) number assigned to this provider is 1295066033.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rebecca Morrow, PA-C has received a total of $2,302 in payments from pharmaceutical and medical device companies, with $974.49 received in 2024. These payments were reported across 77 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,239).
As a Medicare-enrolled provider, Morrow has provided services to 2,114 Medicare beneficiaries, totaling 3,466 services with total Medicare billing of $126,114. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Other Specialties Physician Assistant
- Location Henderson, NV
- Active Since 01/19/2010
- Last Updated 12/15/2015
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1295066033
Products in Payments
- Otezla (Drug) $462.48
- VTAMA (Drug) $236.87
- TALTZ (Drug) $226.43
- HUMIRA (Biological) $199.27
- SKYRIZI (Biological) $198.15
- Zoryve (Drug) $131.94
- COSENTYX (Drug) $123.10
- TREMFYA (Drug) $89.54
- ADBRY (Biological) $74.62
- Enbrel (Biological) $62.61
- OPZELURA (Drug) $53.70
- Cimzia (Drug) $49.58
- RINVOQ (Biological) $36.49
- EUCRISA (Drug) $31.78
- DUPIXENT (Biological) $29.59
- ILUMYA (Biological) $29.32
- SPEVIGO (Drug) $29.27
- OLUMIANT (Drug) $18.79
- AMJEVITA (Biological) $18.03
- Sotyktu (Drug) $17.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Henderson
Anna Liang, Physician Assistant, PHYSICIAN ASSISTANT
Physician Assistant — Payments: $9,518
Physician Assistant $9,518
Rachel Tennis, Pa-C, PA-C
Physician Assistant — Payments: $8,011
Physician Assistant $8,011
Stephanie Shibata, Pa-C, PA-C
Physician Assistant — Payments: $7,733
Physician Assistant $7,733
Benjamin Reese, Pa-C, PA-C
Physician Assistant — Payments: $6,807
Physician Assistant $6,807
Andrea Alessi, Pa, PA
Physician Assistant — Payments: $6,647
Physician Assistant $6,647
Laurie Michlin, Apn, APN
Physician Assistant — Payments: $6,402
Physician Assistant $6,402